CNVIF
Conavi Medical Corp. focuses on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. It offers Novasight Hybrid System, a system that combines intravascular ultrasound and optical coherence tomography to enable simultaneous and co-registered imaging of coronary arteries. Conavi Medical Corp. is based in Toronto, Canada.
CNVIF (CNVIF) - Total Assets
Latest total assets as of September 2025: $12.44 Million USD
Based on the latest financial reports, CNVIF (CNVIF) holds total assets worth $12.44 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
CNVIF - Total Assets Trend (2024–2025)
This chart illustrates how CNVIF’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
CNVIF - Asset Composition Analysis
Current Asset Composition (September 2025)
CNVIF's total assets of $12.44 Million consist of 66.5% current assets and 33.5% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 46.9% |
| Accounts Receivable | $407.00K | 3.3% |
| Inventory | $341.00K | 2.7% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $2.15 Million | 17.3% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2024–2025)
This chart illustrates how CNVIF's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: CNVIF's current assets represent 66.5% of total assets in 2025, an increase from 41.2% in 2024.
- Cash Position: Cash and equivalents constituted 46.9% of total assets in 2025, up from 5.1% in 2024.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 17.0% of total assets, an increase from 0.0% in 2024.
- Asset Diversification: The largest asset category is intangible assets at 17.3% of total assets.
CNVIF Competitors by Total Assets
Key competitors of CNVIF based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
CNVIF - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - CNVIF generates 0.73x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - CNVIF is currently not profitable relative to its asset base.
CNVIF - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.01 | 2.21 | 2.21 |
| Quick Ratio | 0.97 | 2.21 | 2.21 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $58.00K | $ 2.38 Million | $ 2.38 Million |
CNVIF - Advanced Valuation Insights
This section examines the relationship between CNVIF's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 2.14 |
| Asset Growth Rate (YoY) | 45.3% |
| Total Assets | $12.44 Million |
| Market Capitalization | $26.67 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values CNVIF's assets at a significant premium ( 2.14x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: CNVIF's assets grew by 45.3% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for CNVIF (2024–2025)
The table below shows the annual total assets of CNVIF from 2024 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-09-30 | $12.44 Million | +45.35% |
| 2024-09-30 | $8.56 Million | -- |